|
|
|
| |
|
|
| |
The latest ophthalmology / optometry news from News Medical |
|
|
|
 | | |  Diabetes drugs linked to higher risk of rare optic nerve damage New research links two widely used diabetes drugs, semaglutide or tirzepatide, to a rare but potentially vision-threatening eye condition, raising questions about drug-specific risks and the need for closer monitoring. Study: Semaglutide or Tirzepatide and Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes. Image credit: Vince Scherer/Shutterstock. | | | | |  New AAV gene therapy reverses age-related macular degeneration Neovascular age-related macular degeneration (nAMD) is a progressive eye disease characterized by choroidal neovascularization and subretinal hemorrhage and exudation, leading to vision impairment. Current first-line treatment for nAMD are anti-VEGF agents, which has shown promising therapeutics outcomes. | |
|
|
| | | | | Millions of Americans have altered vision, ranging from blurriness to blindness. But not everyone wants to wear prescription glasses or contact lenses. | | | | |  A diet rich in omega-3 fatty acids, found predominantly in fish oils, may help ward off the development of short sightedness (myopia) in children, while a high intake of saturated fats, found in foods such as butter, palm oil, and red meat, may boost the risk of the condition, finds research published online in the British Journal of Ophthalmology. | |
|
|
|
|
|
|
|
